通脉丸治疗颈动脉粥样硬化斑块40例临床观察  

Clincal Research on the Tongmai Wan in Treating Cadotid Atherosclerotic Plaque

作　　者：徐桂范[1] 

机构地区：[1]哈尔滨医科大学第五临床医学院药剂科,黑龙江大庆163316

出　　处：《黑龙江医学》2008年第6期434-435,共2页Heilongjiang Medical Journal

摘　　要：目的探讨通脉丸治疗颈动脉粥样硬化斑块的临床疗效。方法用舒降之做为对照,服药前后记录颈动脉管腔直径(CCAD)、内中膜厚度(IMT)、收缩期峰值血流速度(SV)、舒张期峰值血流速度(DV)、阻力指数(RI)、搏动指数(PI),斑块体和性质。结果应用通脉丸治疗后,病人颈动脉粥样硬化斑块体积缩小或消失。CCAD增加I、MT变薄、SV增加、DV增加、RI减少、PI增加,与对照组相比,差异无显著性(P>0.05)。结论通脉丸治疗颈动脉粥样硬化斑块有明显疗效。Objective To observe the clinical effect of the Tomgmai wan in treating carotid atherosclerotic plaque. Methods 80 patients with carotid atherosclerotic plaque were divided into treatment group （Tongrnai wan group - and control group （Sicastin）. Befor and after the treatment, the Plaque. volume, plaque, type, CCAD, IMT, SV, DV, RI. PI, Symptoms, signs, were observed. Results Volume of plaque reducing or disappearing, CCAD increasing, IMT thinning, SV increasing, DV increasing, RI reducing, PI increasing. Obvious rise of NO, clinical symptoms and signs disappeanng or improuving. The data in the two groups has no sigrtificantdifference （ P 〉 0.05）. Conclusion Conclusion the Tongmai wan have good effect to the treatment of carotid atherosclerotic plaque.

关 键 词：颈动脉粥样硬化 通脉丸 治疗 

分 类 号：R543.4[医药卫生—心血管疾病]